Predictors of denosumab efficacy in treating osteoporosis in patients with rheumatoid arthritis: a Japanese multicenter study.
In conclusions, denosumab increased BMD in RA patients with osteoporosis. The combined use of biologics and denosumab may provide useful treatment options.
PMID: 31849375 [PubMed - in process]
Source: Nagoya Journal of Medical Science - Category: International Medicine & Public Health Tags: Nagoya J Med Sci Source Type: research
More News: Arthritis | Biomedical Science | International Medicine & Public Health | Japan Health | Orthopaedics | Osteoporosis | Rheumatoid Arthritis | Rheumatology | Science | Study | Xgeva